First Trust Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-81,912
| Closed | -$713K | – | 2376 |
|
|
2024
Q1 | $713K | Sell |
81,912
-217,333
| -73% | -$2.64M | ﹤0.01% | 2069 |
|
|
2023
Q4 | $3.42M | Buy |
+299,245
| New | +$2.96M | ﹤0.01% | 1488 |
|
|
2023
Q3 | – | Sell |
-228,999
| Closed | -$2.44M | – | 2434 |
|
|
2023
Q2 | $2.44M | Buy |
228,999
+59,658
| +35% | +$641K | ﹤0.01% | 1605 |
|
|
2023
Q1 | $1.78M | Sell |
169,341
-227,512
| -57% | -$2.55M | ﹤0.01% | 1726 |
|
|
2022
Q4 | $4.92M | Sell |
396,853
-105,809
| -21% | -$1.2M | 0.01% | 1205 |
|
|
2022
Q3 | $5.21M | Buy |
502,662
+134,558
| +37% | +$1.53M | 0.01% | 1171 |
|
|
2022
Q2 | $4.24M | Sell |
368,104
-90,899
| -20% | -$1.07M | 0.01% | 1321 |
|
|
2022
Q1 | $5.77M | Buy |
459,003
+181,729
| +66% | +$2.08M | 0.01% | 1249 |
|
|
2021
Q4 | $3.23M | Buy |
277,274
+149,167
| +116% | +$1.83M | ﹤0.01% | 1587 |
|
|
2021
Q3 | $1.67M | Buy |
+128,107
| New | +$1.66M | ﹤0.01% | 1831 |
|
|
2021
Q2 | – | Sell |
-47,780
| Closed | -$534K | – | 2517 |
|
|
2021
Q1 | $534K | Sell |
47,780
-71,435
| -60% | -$755K | ﹤0.01% | 2194 |
|
|
2020
Q4 | $1.36M | Buy |
119,215
+8,405
| +8% | +$92K | ﹤0.01% | 1763 |
|
|
2020
Q3 | $997K | Sell |
110,810
-85,712
| -44% | -$852K | ﹤0.01% | 1764 |
|
|
2020
Q2 | $2.03M | Sell |
196,522
-31,728
| -14% | -$325K | ﹤0.01% | 1368 |
|
|
2020
Q1 | $2.3M | Buy |
228,250
+214,954
| +1,617% | +$2.53M | 0.01% | 1208 |
|
|
2019
Q4 | $177K | Sell |
13,296
-31,645
| -70% | -$349K | ﹤0.01% | 2333 |
|
|
2019
Q3 | $386K | Sell |
44,941
-24,143
| -35% | -$235K | ﹤0.01% | 2209 |
|
|
2019
Q2 | $756K | Buy |
+69,084
| New | +$774K | ﹤0.01% | 1964 |
|
|
2019
Q1 | – | Sell |
-130,059
| Closed | -$1.13M | – | 2429 |
|
|
2018
Q4 | $1.13M | Sell |
130,059
-77,311
| -37% | -$887K | ﹤0.01% | 1789 |
|
|
2018
Q3 | $3.21M | Buy |
207,370
+147,916
| +249% | +$2.34M | 0.01% | 1394 |
|
|
2018
Q2 | $952K | Buy |
+59,454
| New | +$880K | ﹤0.01% | 1956 |
|
|
2017
Q4 | – | Sell |
-90,639
| Closed | -$1.2M | – | 2423 |
|
|
2017
Q3 | $1.2M | Sell |
90,639
-22,471
| -20% | -$309K | ﹤0.01% | 1768 |
|
|
2017
Q2 | $1.79M | Buy |
113,110
+19,125
| +20% | +$278K | ﹤0.01% | 1556 |
|
|
2017
Q1 | $1.34M | Sell |
93,985
-70,151
| -43% | -$959K | ﹤0.01% | 1726 |
|
|
2016
Q4 | $2.1M | Buy |
164,136
+32,782
| +25% | +$414K | 0.01% | 1420 |
|
|
2016
Q3 | $1.75M | Buy |
131,354
+85,941
| +189% | +$1M | 0.01% | 1411 |
|
|
2016
Q2 | $497K | Buy |
+45,413
| New | +$444K | ﹤0.01% | 1956 |
|
Other funds holding IRWD
SCM
AC
B
First Trust Advisors's IRWD Position: Q2 2024 in Review
First Trust Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 81,912 shares — an estimated $713K sold.
First Trust Advisors first reported a position in IRWD in Q2 2016 and held it in 27 quarters. The position peaked at $5.77M in Q1 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.
- First Trust Advisors reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- First Trust Advisors sold 81,912 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $713K.
- First Trust Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2016 and held it in 27 quarters.
- First Trust Advisors's Ironwood Pharmaceuticals position peaked at $5.77M in Q1 2022.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.
Based on First Trust Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.